F. Legouté

ORCID: 0000-0002-7652-0120
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Advanced Radiotherapy Techniques
  • Colorectal and Anal Carcinomas
  • Oral health in cancer treatment
  • Management of metastatic bone disease
  • Colorectal Cancer Surgical Treatments
  • Brain Metastases and Treatment
  • Head and Neck Surgical Oncology
  • Lung Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Neurofibromatosis and Schwannoma Cases
  • Multiple and Secondary Primary Cancers
  • Colorectal Cancer Screening and Detection
  • Ear and Head Tumors
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced X-ray and CT Imaging
  • Telemedicine and Telehealth Implementation
  • Colorectal Cancer Treatments and Studies
  • Radiation Dose and Imaging
  • Electronic Health Records Systems
  • Prostate Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Genetic factors in colorectal cancer
  • Lung Cancer Treatments and Mutations

Roche (France)
2022

Centre Hospitalier Départemental Vendée
2022

Institut de Cancérologie de l'Ouest
2017-2020

Centre Jean Bernard
2016

Low-level laser therapy (LLLT) also called Photobiomodulation (PBMT) could reduce oral mucositis (OM) incidence and severity in head neck cancer patients treated by chemoradiotherapy, however randomised data about efficacy safety are missing with curative dose 4 J/cm2. This phase III trial was conducted cavity, or oro/hypopharyngeal cancers (stage IV). Patients were lasertherapy on OM lesions grade ≥ 2 (4 J/cm2 placebo), during chemoradiotherapy until recovery. Severity of (incidence...

10.1186/s13014-019-1292-2 article EN cc-by Radiation Oncology 2019-05-22

Although salvage and adjuvant radiotherapy (RT) are effective in prostate cancer (PC) patients, 30%-40% of men will have disease progression. The objective was to describe the pattern recurrence PC patients with biochemical failure (BF) following postoperative RT.We retrospectively analyzed 935 treated from 2009 2019 or RT at Institut de Cancérologie l'Ouest. Of these, 205 (22%) developed BF whom 166 underwent imaging. Patients identified radiologic prior any specific treatment were included...

10.3389/fonc.2021.787347 article EN cc-by Frontiers in Oncology 2022-01-05

Abstract BackgroundIn unresectable metastatic rectal cancers, the surgery of primitive tumor remains highly debated. Chemoradiotherapy (CRT) could allow sufficient local control in order to avoid major and sometimes mutilating surgery. Dose escalation during CRT increase this control. The aim study was evaluate feasibility tolerance a with radiation dose delivered intensity modulated radiotherapy (IMRT) simultaneous integrated boost (SIB), low middle cancers.MethodsThis multicenter phase I...

10.21203/rs.3.rs-127929/v1 preprint EN cc-by Research Square (Research Square) 2020-12-16

Background: In unresectable metastatic rectal cancers, surgery of primary tumor remains highly debated. Pelvic Chemoradiotherapy (CRT) could allow sufficient local control in order to avoid major and sometimes mutilating surgery. Dose escalated CRT increase control. The aim this study was evaluate the feasibility tolerance a with radiation dose escalation using intensity modulated radiotherapy (IMRT) simultaneous integrated boost (SIB), low middle cancers. Methods: This multicenter phase...

10.26502/jcsct.5079121 article EN Journal of Cancer Science and Clinical Therapeutics 2021-01-01
Coming Soon ...